Skip to main content
. 2015 Nov 8;2015:279109. doi: 10.1155/2015/279109

Figure 2.

Figure 2

Kaplan-Meier survival curves illustrating the overall survival (OS) in breast cancer patients with the ABCG2 G34A polymorphism. (a) Patients with anthracycline-based chemotherapy (n = 761); (b) patients with ER positive status after anthracycline-based chemotherapy (n = 444); (c) patients with PR positive status after anthracycline-based chemotherapy (n = 418). Log-rank P values were indicated.